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figure 1. Distribution of time to onset of deep-incisional (DI) and organ space (OS) surgical site infections (SSIs) following total knee
replacement (TKR), total hip replacement (THR), mastectomy with implant reconstruction, and coronary artery bypass grafting (CABG)
surgeries. Duration of postprocedure follow-up for DI/OS SSI was 365 days for TKR, THR, and mastectomy with implant and 60 days
for CABG. An asterisk indicates that the surveillance window was limited to 60 days for CABG.
Beyond 30 Days: Does Limiting the
Duration of Surgical Site Infection Follow-
up Limit Detection?
Concern over consistency and completeness of surgical site
infection (SSI) surveillance has increased due to public re-
porting of hospital SSI rates and imminent nonpayment rules
for hospitals that do not meet national benchmarks.1 Already,
hospitals no longer receive additional payment from the Cen-
ters for Medicare and Medicaid Services (CMS) for certain
infections following coronary artery bypass graft (CABG) sur-
gery, orthopedic procedures, and bariatric surgery.2
One major concern is incomplete and differential post-
discharge surveillance. At present, substantial variation exists
in how and whether hospitals identify SSI events after the
hospitalization in which the surgery occurred. Parameters
used for SSI surveillance such as the duration of the window
of time that surveillance takes place following the surgical
procedure can impact the completeness of surveillance data.
Determination of the optimal surveillance time period in-
volves balancing the potential increased case ascertainment
associated with a longer follow-up period with the increased
resources that would be required. Currently, the time window
for identifying potentially preventable SSIs related to events
at the time of surgery is not fully standardized. The Centers
for Disease Control and Prevention National Healthcare Sur-
veillance Network requires a 365-day postoperative surveil-
lance period for procedures involving implants and a 30-day
period for nonimplant procedures.3 In contrast, the National
Surgical Quality Improvement Program and the Society of
Thoracic Surgeons systems employ 30-day postoperative sur-
veillance regardless of implant. As consensus builds toward
national quality measures for hospital-specific SSI rates, it
will be important to assess the frequency of events beyond
the 30-day postsurgical window that may quantify the value
of various durations of surveillance and ultimately inform
the choice of specific outcome measures.
We evaluated the fraction of deep and organ/space SSIs
detected beyond 30 days following CABG, orthopedic pro-
cedures, and mastectomy with implant surgical procedures
to inform whether a longer SSI surveillance time period iden-
tifies sufficient additional SSI cases to warrant additional sur-
veillance resources.
SSIs were identified as part of retrospective cohort studies
at 5 hospitals following total hip replacements (THRs) and
total knee replacements (TKRs) performed from January 1,
2007, to December 31, 2007.4 SSIs with onset of infection
within 365 days of surgery were identified by (a) routine
surveillance by hospital infection prevention programs, which
was not standardized and commonly involved a combination
of review of microbiology records and evaluation of read-
missions or reoperations that came to attention, and (b) cases
flagged by a previously validated algorithm involving anti-
biotic data, administrative diagnostic codes, and readmission
criteria.5
Previously identified post-CABG SSIs were identified from
a 2005 retrospective cohort study of Medicare beneficiaries
undergoing CABG in US hospitals ranked in the top and
bottom deciles based on case mix–adjusted probabilities of
an SSI-related claim code within 60 days of surgery. The
Romano score was used for case mix adjustment and was
demonstrated as a significant predictor of SSI.6 Randomly
selected medical records were reviewed for SSI.
Last, we evaluated previously identified SSI cases following
mastectomy procedures involving implantation of prosthetic
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material from an academic medical center (August 2005–De-
cember 2007). Data were collected from the surgical admis-
sion, readmissions, and clinic visits within 1 year of surgery.7
All SSIs were limited to those involving deep-incisional
(DI) or organ/space (OS) infections. Time from surgery to
SSI onset was calculated for all SSIs and grouped into less
than or equal to 30 days and 31–60 days for CABG, while
TKR, THR, and mastectomy procedures included additional
groupings of 61–90 and 91–365 days.
We identified 27 SSIs following 1,666 TKRs, 21 SSIs fol-
lowing 1,691 THRs, 477 SSIs following 23,376 CABGs, and
54 SSIs following 327 mastectomies with implants (Figure 1).
Based on these identified SSIs, TKR required 60 days to iden-
tify the majority of cases.8 By 90 days after procedure, 100%
of known DI/OS SSIs were identified for THR, 70% of DI/
OS SSIs for TKR, and 87% of DI/OS SSIs for mastectomy
with implants. Limiting postoperative SSI surveillance to 30
days would lead to underreporting of approximately one-
quarter to two-thirds of DI/OS SSIs across the 4 procedures
surveyed. Confining postoperative SSI surveillance to 60 days,
as was done for all CABG procedures, results in detection of
the vast majority of DI/OS SSIs following THR and mastec-
tomy-plus-implant procedures but only half of DI/OS SSIs
following TKR. In contrast, a 90-day window detected most
DI/OS SSIs across these 3 procedures. A limitation of all SSI
estimates across THR, TKR, and mastectomy-plus-implant
procedures was that follow-up was confined to the hospital
where the index procedure was performed. Therefore, results
represent minimum estimates of infection because postdis-
charge outpatient events and SSIs identified at other hospitals
were not captured. In contrast, the use of insurer claims to
identify CABG SSIs regardless of the location of medical care
would allow for more confidence that all medically attended
DI/OS infections were captured.6
Impending CMS SSI surveillance measures for mandatory
reporting should consider including DI/OS SSI surveillance
periods for TKR, THR, CABG, and mastectomy-plus-implant
procedures beyond 30 days. Nevertheless, additional research
is needed to assess whether resources to extend surveillance
to 365 days after procedures is prudent, given limited re-
sources, the fact that most DI/OS SSIs are captured within
90 days, and the uncertainty whether SSIs occurring that long
after surgery are in fact due to preventable issues at the time
of the operation.
Regardless of which duration of postdischarge surveillance
is selected, assurance that hospitals are conducting postdis-
charge surveillance using standardized methods is necessary
for interhospital comparison. Training and validation to en-
sure similarly comprehensive SSI capture across hospitals is
critical for valid public reporting used to determine Medicare
payment. In addition, comparison and improvement of ex-
isting case mix adjustors should be performed to properly
account for different patient population risks for SSI. Early
successful explorations into the use of large networks of
claims-based databases appear promising in this regard since
both case mix adjustment and claims-based algorithms to
trigger chart review have been shown to be superior to routine
surveillance performed by hospital infection prevention pro-
grams for SSI detection and can be used to standardize post-
discharge SSI surveillance.6,9,10
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Latent Tuberculosis Infection in Nurses
Exposed to Tuberculous Patients Cared for
in Rooms without Negative Pressure after
the 2011 Great East Japan Earthquake
In the aftermath of the Great East Japan Earthquake on March
11, 2011, Miyagi Cardiovascular and Respiratory Center, a
designated tuberculosis (TB) center, was unable to provide
negative pressure rooms as a result of lack of electricity and
damage to our generator. In our TB ward, infection control
measures are performed as follows: the use of N95 respirators
by healthcare personnel (HCP), independent ventilation sys-
tems with rooms maintained at negative pressure with respect
to the corridor and direct out exhausted air, and respiratory
isolation of TB patients.
Despite evidence demonstrating the association between
ventilation and the transmission of TB,1 there are no data
assessing the importance of negative pressure rooms in the
airborne transmission of TB following a natural disaster. In
addition, HCP are at risk for TB exposure and infection when
they care for patients in healthcare settings.2 In this study,
we investigated the prevalence of latent tuberculosis infection
(LTBI) in nurses who were exposed to patients with smear-
positive TB in rooms that could not be maintained under
negative pressure after the earthquake.
All negative pressure rooms in the TB ward were unavail-
able on March 11–15 (5 days) and April 7 (1 day) because
of seismic damage to the ventilation system. The ventilation
system was not designed to be supplied by the backup power
generation system. It was not possible to open room windows
for ventilation because our hospital was located in a very cold
area.
All study participants completed self-administered ques-
tionnaires about working time in the TB unit while negative
pressure rooms were not available, exposure time to smear-
positive TB patients, exposure to aerosol-generating proce-
dures such as tracheal aspiration, and personal risk factors
for TB infection. The whole-blood interferon-g release assay
(IGRA) was performed to identify LTBI by using Quanti-
FERON-TB Gold In-Tube (Cellestis) on May 19 or May 26,
2011 (10–11 weeks after the earthquake), because all nurses
were already tuberculin skin test (TST) positive at baseline
and had a previous history of bacillus Calmette-Gue´rin (BCG)
vaccination. We could not obtain IGRA results at baseline
because of difficulties with processing the blood test just after
the earthquake.
Fortunately, we had stocked sufficient N95 respirators, but
compliance of some nurses was poor. The nursing station in
the TB ward was connected via a corridor to patient rooms,
and most HCP did not wear masks while working at the
station. At the time during which there was inadequate ven-
tilation, there were 23 smear-negative TB patients and 2
smear-positive TB patients: 1 was graded 3 in sputum smear
with a TB strain resistant to isoniazid; the other was graded
1 according to the World Health Organization scale.3 Fifteen
nurses, including 6 in team X, 7 in team Y, and 2 other nurses,
were recruited into this study. Team Y mainly provided care
for patients with smear-positive TB.
The questionnaire demonstrated that no participants had
a history of TB and none had a risk factor for TB infection,
including human immunodeficiency virus infection, immu-
nodeficiency, use of high-dose steroids or immunosuppressive
drugs, diabetes mellitus, or malignancy. Overall, 3 (20%) of
15 nurses were IGRA positive (Table 1). Menzies et al4 re-
ported that the prevalence of LTBI among HCP was 63% in
low- and middle-income countries and 24% in high-income
countries. It is estimated that a prevalence of LTBI among
Japanese HCP is approximately 10%.5 Two IGRA-positive
nurses were derived from team Y, whereas all nurses in team
X were IGRA negative. Two (50%) of the 4 nurses who were
exposed to smear-positive TB for more than 9 hours were
IGRA positive, whereas 1 (9.1%) of the 11 nurses who were
exposed to smear-positive TB for less than 5 hours was IGRA
positive. Although airline passengers who are seated for more
than 8 hours in the same or adjoining rows are more likely
to be infected than other passengers, the optimal cutoff du-
ration of exposure is undetermined in evaluating the likeli-
hood of TB infection at close contact in the healthcare set-
ting.6
TST has very limited value for screening LTBIs among HCP
in Japan according to the possibility of false-positive results
in people who have received BCG vaccination, while
